Randsborg Per-Henrik, Brinchmann Jan, Løken Sverre, Hanvold Heidi Andreassen, Aae Tommy Frøseth, Årøen Asbjørn
Department of Orthopedic Surgery, Akershus University Hospital, Lørenskog, Norway.
Department of Immunology and Norwegian Center for Stem Cell Research, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
BMC Musculoskelet Disord. 2016 Mar 8;17:117. doi: 10.1186/s12891-016-0969-z.
Focal cartilage injuries in the knee might have devastating effect due to the predisposition of early onset osteoarthritis. Various surgical treatment options are available, however no statistically significant differences have been found between the different surgical treatments. This supports the suggestion that the improvement might be a result of the post-operative rehabilitation rather than the surgery itself. Autologous chondrocyte implantation (ACI) has become a recognized treatment option for larger cartilage lesions in the knee. Although ACI has been compared to other surgical treatment such as microfracture and mosaicplasty, it has never been directly compared to simple arthroscopic debridement and rehabilitation alone. In this study we want to increase clinical and economic knowledge about autologous chondrocyte implantation compared to arthroscopic debridement and physical rehabilitation in the short and long run.
METHODS/DESIGN: We will conduct a randomized controlled trial to compare ACI with simple arthroscopic debridement (AD) and physiotherapy for the treatment of cartilage lesions in the knee. The study will include a total of 82 patients, both men and non-pregnant women, with a full thickness cartilage defect in the weight bearing area of the femoral condyles or trochlea larger than 2 cm2. The lesion must be symptomatic, with a Lysholm score less than 75. The two treatment groups will receive identical rehabilitation protocol according to a modification of Wondrasch et al., which is an active rehabilitation and education program divided into 3 phases: accommodation, rehabilitation and return to activity. The patients will be followed for 24 months, with additional late follow-ups at 5 and 10 years to monitor the potential onset of osteoarthtitis. The primary outcome measure will be the difference in the KOOS knee-related quality of life (QoL) subscore in the ACI group compared to the AD group at 2 years. A combination of self-explanatory questionnaires, clinical parameters, clinical hop tests and radiographs and Magnetic Resonance Imaging (MRI) will be used as secondary endpoints.
This is the first study with a high level of evidence to compare ACI with simple debridement and physiotherapy for the treatment of isolated symptomatic full thickness lesions of the knee.
ClinicalTrial NCT02636881 (21 December 2015).
膝关节局灶性软骨损伤可能因早期发生骨关节炎的倾向而产生破坏性影响。目前有多种手术治疗选择,但不同手术治疗之间未发现统计学上的显著差异。这支持了以下观点:病情改善可能是术后康复的结果,而非手术本身。自体软骨细胞移植(ACI)已成为治疗膝关节较大软骨损伤的一种公认治疗选择。尽管ACI已与其他手术治疗方法(如微骨折和镶嵌植骨术)进行了比较,但从未直接与单纯关节镜下清创和康复治疗进行比较。在本研究中,我们希望从短期和长期两方面增加关于自体软骨细胞移植与关节镜下清创和物理康复治疗相比的临床和经济学知识。
方法/设计:我们将进行一项随机对照试验,比较ACI与单纯关节镜下清创术(AD)及物理治疗对膝关节软骨损伤的治疗效果。该研究将总共纳入82例患者,包括男性和未怀孕女性,其股骨髁或滑车负重区存在面积大于2平方厘米的全层软骨缺损。该损伤必须有症状,Lysholm评分低于75分。根据Wondrasch等人修改后的方案,两个治疗组将接受相同的康复方案,这是一个分为3个阶段的积极康复和教育计划:适应期、康复期和恢复活动期。患者将接受24个月的随访,并在5年和10年进行额外的后期随访,以监测骨关节炎的潜在发病情况。主要结局指标将是2年时ACI组与AD组相比,膝关节损伤与骨关节炎疗效评分(KOOS)中与膝关节相关的生活质量(QoL)子评分的差异。一系列自解释问卷、临床参数、临床单腿跳跃试验、X线片以及磁共振成像(MRI)将用作次要终点。
这是第一项具有高证据水平的研究,比较ACI与单纯清创术及物理治疗对孤立性有症状的膝关节全层损伤的治疗效果。
ClinicalTrial NCT02636881(2015年12月21日)。